How one scientist is changing the game for dengue treatment. With diagnostics, vaccine and a drug in tow—Navin Khanna is emerging as the judge, jury, and executioner for dengue, a virus which infects millions every year. But only a fraction of which gets reported
Everything’s warmer this winter in Delhi, even a dengue discussion. For years Navin Khanna has studied dengue and other infections with a quiet purposefulness. As he settles into the cane chair, at the faculty lounge and boots up his MacBook, the academic aloofness of the place recedes. In the 26 years that Khanna has been at the International Centre for Genetic Engineering and Biotechnology (ICGEB), he has developed 26 diagnostic kits; 23 of which are in the market.
“It wasn’t mathematics,” he says, with a dismissive laugh. “India is the epicentre of dengue but we…
Sign up to read this story for free right now
Stories on The Ken are available only for its subscribers. Join us now to get instant access.
Complete access to all stories on The Ken. Rs. 2,750/year or Rs. 900/quarter
Dear subscriber - a lot of hard work goes into the journalism we put out. While sharing snippets or limited screenshots is okay, please avoid printing and sharing our entire articles as PDFs. Our plans are very affordable - please ask your friends to subscribe.